Registration of securities issued in business combination transactions

Income Taxes (Tables)

v3.23.2
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of deferred tax assets
 

As of December 31,

   

2022

 

2021

Current:

 

 

 

 

 

 

 

 

Accrued expenses

 

$

133,591

 

 

$

144,077

 

Stock compensation

 

 

354,274

 

 

 

1,800,762

 

Net operating loss carryforward

 

 

20,980,803

 

 

 

19,481,137

 

Research and development credit carry forward

 

 

1,340,317

 

 

 

252,536

 

Capitalized research and development

 

 

1,419,818

 

 

 

 

Total deferred tax assets

 

 

24,228,803

 

 

 

21,678,512

 

Valuation allowance

 

 

(24,228,803

)

 

 

(21,678,512

)

Deferred tax asset, net of valuation allowance

 

$

 

 

$

 

Schedule of federal income tax rate to effective tax rate
 

For the Years Ended
December 31,

   

2022

 

2021

U.S. statutory federal rate

 

21.0

%

 

21.0

%

State income taxes, net of federal tax

 

7.1

%

 

7.0

%

Permanent differences

 

0.1

%

 

(2.5

)%

Prior year true-ups

 

(10.9

)%

 

(2.7

)%

R&D tax credit

 

3.7

%

 

0.1

%

Change in valuation allowance

 

(21.0

)%

 

(22.9

)%

Income tax provision (benefit)

 

%

 

%

Schedule of income tax provision consists
 

For the Years Ended
December 31,

   

2022

 

2021

Federal

 

 

 

 

 

 

 

 

Current

 

$

 

 

$

 

Deferred

 

 

(1,909,246

)

 

 

(2,723,112

)

State and local

 

 

 

 

 

 

 

 

Current

 

 

 

 

 

 

Deferred

 

 

(641,044

)

 

 

(905,577

)

Change in valuation allowance

 

 

2,550,290

 

 

 

3,628,689

 

Income tax provision (benefit)

 

$

 

 

$